Compliance in Chronic Diseases in the Adolescence Period
Authors:
P. Krásničanová; O. Pozler
Authors place of work:
Dětská klinika LF a FN, Hradec Králové
přednostka doc. MUDr. E. Pařízková, CSc
Published in the journal:
Čes-slov Pediat 2008; 63 (9): 495-500.
Category:
Review
Summary
Compliance is defined as an extent of adhering to therapeutic drug regimen. The use of more than 80% of drugs from the prescribed number for a certain period of time is characterized as non-compliance. Adolescents represent – due to the natural characteristics of this developmental period – a risk group for the development of non-compliance. Similarly to other age groups, in chronic diseases the periods at risk are especially those without symptoms. The article outlines a survey of forms and factors on non-compliance, methods of evaluation of compliance and their use in pediatric practice.
Key words:
compliance in adolescence, chronic diseases, methods of evaluation of compliance
Zdroje
1. Rapoff MA, Belmont JM, Lindsley CB, Olson NY. Electronically monitored adherence to medications by newly diagnosed patients with juvenile rheumatoid arthritis. Arthritis Rheum. 2005;53(6): 905–910.
2. Osterberg L, Blaschke T. Adherence to medication. N. Engl. J. Med. 2005;353: 487–497.
3. Patterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine 2000;1333: 21–30.
4. Shaw RJ, Palmer L, Blasey C, Sarwal M. A typology of non-adherence in pediatric renal transplant recipients. Pediatr. Transplant. 2003;7(6): 489–493.
5. Sewitch MJ, Abrahamowicz M, Barkun A, Bitton A, Wild GE, et al. Patient nonadherence to medication in inflammatory bowel disease. Am. J. Gastroenterol. 2003;98(7): 1535–1544.
6. Kyngas HA, Kroll T, Duffy ME. Compliance in adolescents with chronic diseases: a review. J. Adolesc. Hlth 2000;26: 379–388.
7. Rosina R, Crips J, Steinbeck K. Treatment adherence of youth and young adults with and without chronic illnes. Nurs. Hlth Sci. 2003;5: 139–147.
8. Jonasson G, Carlsen KH, Mowinckel P. Asthma drug adherence in a long term clinical trial. Arch. Dis. Child. 2000;83: 330–333.
9. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regiment and medication compliance. Clin. Ther. 2001;23(8): 1296–1310.
10. Mackner L, Crandall WV. Oral medication adherence in pediatric inflammatory bowel disease. Inflamm. Bowel Dis. 2005;11(11): 1006–1012.
11. Lopez San Román A, Bermejo F, Carrera E, Perez-Abad M, Boixeda D. Adherence to treatment in inflammatory bowel disease. Rev. Esp. Enferm. Dig. 2005;97(4): 249–257.
12. Jonasson G, Carrlsen K, Sodaal A, Jonasson C, Mowinckel P. Patient compliance in a clinical trial with inhaled budesonide in children with mild asthma. Eur. Respir. J. 1999;14(1): 150–154.
13. Düsing R, Lottermosser K, Mendgen T. Compliance with drug therapy – new answers to an old question. Nephrol. Dial. Transplant. 2001;16: 1317–1321.
Štítky
Neonatology Paediatrics General practitioner for children and adolescentsČlánok vyšiel v časopise
Czech-Slovak Pediatrics
2008 Číslo 9
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- The Importance of Limosilactobacillus reuteri in Administration to Diabetics with Gingivitis
Najčítanejšie v tomto čísle
- Contribution to Liver Disorders in Childhood – Analysis of the Histological Findings in 100 Core Needle Biopsies
- Suckling Colics
- Recommended Procedure for Prevention and Therapy of Child Obesity
- The Risk of Accepting New Standard of the World Health Organization for Evaluating Growth of the Czech Child Population (0–5 years of age)